{"id":"erythropoietin-carried-on-chitosan-carrier","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Thromboembolism"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Erythropoietin (EPO) is a glycoprotein hormone that activates the erythropoietin receptor (EPOR) on erythroid progenitor cells in the bone marrow, promoting their proliferation, differentiation, and survival. The chitosan carrier is a biocompatible polysaccharide designed to enhance drug stability, enable sustained release, and potentially improve mucosal or systemic absorption of the EPO payload.","oneSentence":"Erythropoietin stimulates red blood cell production by binding to erythropoietin receptors on bone marrow progenitor cells, delivered via a chitosan carrier for improved bioavailability and sustained release.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:39:22.536Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anemia associated with chronic kidney disease"},{"name":"Anemia in cancer patients receiving chemotherapy"}]},"trialDetails":[{"nctId":"NCT06513039","phase":"PHASE4","title":"Evaluation of Erythropoietin on Alveolar Ridge Preservation","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-01-01","conditions":"Alveolar Bone Loss","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Erythropoietin carried on chitosan carrier","genericName":"Erythropoietin carried on chitosan carrier","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Erythropoietin stimulates red blood cell production by binding to erythropoietin receptors on bone marrow progenitor cells, delivered via a chitosan carrier for improved bioavailability and sustained release. Used for Anemia associated with chronic kidney disease, Anemia in cancer patients receiving chemotherapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}